糖尿病低血糖高危人群的管理:内分泌学会临床实践指南
该指南由多学科专家组使用GRADE方法制定,针对糖尿病患者低血糖风险与预防提出10条推荐,包括有条件推荐实时连续葡萄糖监测(CGM)、算法驱动胰岛素泵、长效和速效胰岛素类似物及住院患者CGM,强推荐结构化糖尿病教育、无需重配的胰高血糖素制剂、多次每日注射的1型糖尿病患者使用实时CGM及住院血糖管理项目。
要点
- 强推荐对低血糖高危人群开展结构化糖尿病教育项目。
- 强推荐成人及儿童严重门诊低血糖使用无需重配的胰高血糖素制剂而非需重配者。
- 有条件推荐1型糖尿病患者使用实时CGM和算法驱动胰岛素泵。
核心结论
- 推荐基于关键结局及可行性、糖尿病患者价值观与偏好等实施因素,可用于指导临床实践和医疗系统改进。
研究设计与样本
- 多学科临床专家组联合患者代表及方法学家,确定10个关于糖尿病患者低血糖的临床问题,开展系统评价,采用GRADE方法评估证据确定性并形成推荐。
主要发现
- 专家组就10个低血糖风险与预防问题达成10条推荐,包括有条件推荐和强推荐。
关键数值与推荐
- 有条件推荐:1型糖尿病患者使用实时CGM和算法驱动胰岛素泵。
- 有条件推荐:低血糖高危的2型糖尿病门诊患者使用CGM。
- 有条件推荐:使用长效和速效胰岛素类似物。
- 有条件推荐:选择低血糖高危的住院人群启动和继续使用CGM。
- 强推荐:对低血糖高危人群开展结构化糖尿病教育项目。
临床怎么用
- 推荐可用于指导临床实践和医疗系统改进,以应对糖尿病患者这一重要并发症。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Hypoglycemia in people with diabetes is common, especially in those taking medications such as insulin and sulfonylureas (SU) that place them at higher risk. Hypoglycemia is associated with distress in those with diabetes and their families, medication nonadherence, and disruption of life and work, and it leads to costly emergency department visits and hospitalizations, morbidity, and mortality. OBJECTIVE: To review and update the diabetes-specific parts of the 2009 Evaluation and Management of Adult Hypoglycemic Disorders: Endocrine Society Clinical Practice Guideline and to address developing issues surrounding hypoglycemia in both adults and children living with diabetes. The overriding objectives are to reduce and prevent hypoglycemia. METHODS: A multidisciplinary panel of clinician experts, together with a patient representative, and methodologists with expertise in evidence synthesis and guideline development, identified and prioritized 10 clinical questions related to hypoglycemia in people living with diabetes. Systematic reviews were conducted to address all the questions. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology was used to assess the certainty of evidence and make recommendations. RESULTS: The panel agreed on 10 questions specific to hypoglycemia risk and prevention in people with diabetes for which 10 recommendations were made. The guideline includes conditional recommendations for use of real-time continuous glucose monitoring (CGM) and algorithm-driven insulin pumps in people with type 1 diabetes (T1D), use of CGM for outpatients with type 2 diabetes at high risk for hypoglycemia, use of long-acting and rapid-acting insulin analogs, and initiation of and continuation of CGM for select inpatient populations at high risk for hypoglycemia. Strong recommendations were made for structured diabetes education programs for those at high risk for hypoglycemia, use of glucagon preparations that do not require reconstitution vs those that do for managing severe outpatient hypoglycemia for adults and children, use of real-time CGM for individuals with T1D receiving multiple daily injections, and the use of inpatient glycemic management programs leveraging electronic health record data to reduce the risk of hypoglycemia. CONCLUSION: The recommendations are based on the consideration of critical outcomes as well as implementation factors such as feasibility and values and preferences of people with diabetes. These recommendations can be used to inform clinical practice and health care system improvement for this important complication for people living with diabetes.
引用
- McCall AL, Lieb DC, Gianchandani R, et al. Management of Individuals With Diabetes at High Risk for Hypoglycemia: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2023. PMID: 36477488. doi:10.1210/clinem/dgac596
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。